Instead of discovering a shortage at the point of care, that real-time usage and inventory trend allows the pharmacy teams to really see that risk earlier and adjust their sourcing, avoid those ...

In today’s Pharma Pulse, bipartisan lawmakers target PBM vertical integration, while pharma giants race to secure tariff-exempt pricing deals.

According to Reuters, some of the pharma companies that were not on the receiving end of President Trump’s May executive order (EO) 2 are interested in pursuing separate agreements in order to avoid ...

Bandy: The statistics that we found within the survey is that four inc five, which is equivalent to about 79%, are saying ...

In today’s Pharma Pulse, the FDA issues a rare “Refusal-to-File" for Moderna’s influenza vaccine, while new research confirms GLP-1s act as potent tools against chronic inflammation.

From a deep dive into pharma 3PL strategy to fresh perspectives on PBM economics and rising quality pressures, the February issue sets the tone for a year of industry insight. The feedback and ...

1. Meijer Announces New Affordable Access to GLP-1 Medications. Meijer. February 10, 2026. Accessed February 11, 2026.

PC: Tecsys’ new survey shows that only 20% of healthcare leaders report having real-time visibility across pharmacy inventory and care settings. What specific visibility gaps are most common today, ...

In today’s Pharma Pulse, the American College of Physicians issues a formal rejection of the term "provider," while Takeda partners with Iambic Therapeutics to accelerate small-molecule discovery ...